清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Real world practice of postoperative radiotherapy for patients with completely resected pIIIA-N2 non-small cell lung cancer: a national survey of radiation oncologists in China

医学 肺癌 放射肿瘤学家 放射治疗 纵隔淋巴结 端口(电路理论) 家庭医学 癌症 外科 内科学 电气工程 转移 工程类
作者
Shujie Zhou,Yirui Zhai,Kaikai Zhao,Yu Men,Xiangjiao Meng,Zhouguang Hui
出处
期刊:Radiation Oncology [Springer Nature]
卷期号:18 (1)
标识
DOI:10.1186/s13014-023-02208-5
摘要

Abstract Background Results from Lung ART and PORT-C trials suggest that postoperative radiotherapy (PORT) cannot routinely be recommended as standard treatment in completely resected pIIIA-N2 NSCLC patients, but their effects on the real-world practice of PORT in China remain unclear. Methods A national cross-section survey was conducted by using an online survey service. Participants were voluntarily recruited using a river sampling strategy. A link to the survey was posted on websites of radiation oncologist associations and tweets from public WeChat accounts. The survey collected the real names of participants to ensure that they were board-certified radiation oncologists. Results A total of 484 radiation oncologists were included with a median age of 40 years (IQR, 35–47). A total of 377 (77.9%) participants were male, and 282 (58.1%) had more than 10 years of clinical experience practicing thoracic radiotherapy. Before Lung ART and PORT-C trials were published, 313 (64.7%) respondents recommended PORT, 11 (2.3%) did not recommend it, and 160 (33.1%) reported that they made decisions based on risk factors. After the presentation of two trials, only 42 (8.7%) did not recommend PORT, while 108 (22.3%) recommended it, and 334 (69.0%) made decisions based on risk factors. The five most commonly considered risk factors among these 334 respondents were as follows: nodal extracapsular extension, the highest lymph node (LN) station involved, the number of dissected mediastinal LN stations, the number of positive mediastinal LN stations, and surgical approaches. In addition, the majority of all 484 respondents recommended a total dose of 50 Gy, lung stump + ipsilateral hilus + regions containing positive LNs as the targeted region, lung V20 < 25%, and heart V30 < 40% as dose constraints for PORT. Conclusion Most Chinese radiation oncologists recommended PORT for completely resected IIIA-N2 NSCLC patients based on risk factors, especially status of LN station.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
潘fujun完成签到 ,获得积分10
8秒前
飘逸问薇完成签到 ,获得积分10
11秒前
橘子海完成签到 ,获得积分10
11秒前
勤劳的颤完成签到 ,获得积分10
16秒前
ROMANTIC完成签到 ,获得积分10
22秒前
大意的晓亦完成签到 ,获得积分10
23秒前
Shandongdaxiu完成签到 ,获得积分10
25秒前
明朗完成签到 ,获得积分10
30秒前
doreen完成签到 ,获得积分10
35秒前
雨后完成签到 ,获得积分10
36秒前
39秒前
lily336699完成签到,获得积分10
41秒前
42秒前
43秒前
美满的皮卡丘完成签到 ,获得积分10
43秒前
踏实的静竹完成签到,获得积分10
57秒前
lily完成签到 ,获得积分10
58秒前
SL完成签到,获得积分10
1分钟前
深情的凝云完成签到 ,获得积分0
1分钟前
SL发布了新的文献求助10
1分钟前
大吴克发布了新的文献求助10
1分钟前
朽木完成签到 ,获得积分10
1分钟前
俊逸的白梦完成签到 ,获得积分0
1分钟前
露露完成签到 ,获得积分10
1分钟前
BINBIN完成签到 ,获得积分10
1分钟前
枫林摇曳完成签到 ,获得积分10
1分钟前
ramsey33完成签到 ,获得积分10
1分钟前
1分钟前
飞龙在天完成签到,获得积分10
2分钟前
LiangRen完成签到 ,获得积分10
2分钟前
chcmy完成签到 ,获得积分0
2分钟前
wx1完成签到 ,获得积分0
2分钟前
su完成签到 ,获得积分10
2分钟前
Ray完成签到 ,获得积分10
2分钟前
yuntong完成签到 ,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
2分钟前
代扁扁完成签到 ,获得积分10
2分钟前
2分钟前
负责的流沙完成签到 ,获得积分10
2分钟前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Востребованный временем 2500
Aspects of Babylonian celestial divination : the lunar eclipse tablets of enuma anu enlil 1500
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
体心立方金属铌、钽及其硼化物中滑移与孪生机制的研究 800
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3450467
求助须知:如何正确求助?哪些是违规求助? 3045952
关于积分的说明 9003800
捐赠科研通 2734611
什么是DOI,文献DOI怎么找? 1500096
科研通“疑难数据库(出版商)”最低求助积分说明 693341
邀请新用户注册赠送积分活动 691477